by John Moore | April 13, 2018
At times it can be challenging to draft commentary on all that is happening across this industry sector. Rather than write short posts for each, I have created an amalgamation of commentary to some of the more newsworthy announcements. Roche Acquires Flatiron Wow, whoever knew that data could be such
by Chilmark Team | December 06, 2017
Over the weekend, CVS announced its intent to acquire Aetna for $69 billion. If approved, it would represent one of the largest M&A deals this decade, and the largest in the healthcare industry. The combined entity will have revenue of more than $220 billion and an EBITDA of $18.5 billion.
by John Moore | September 08, 2017
On Aug. 29th, Optum announced it will acquire The Advisory Board's (ABCO) healthcare business unit for about $1.3 billion. Rumors first began swirling about this acquisition in early July, though the Advisory Board had been "shopping" itself to the market since February. This is a significant play by the acquisitive
by John Moore | December 28, 2016
2016 is heading for the doors, 2017 readily awaits. But what will this New Year bring? One thing for sure, a new president and administration that appears intent on rewriting the rules, be they foreign policy, environmental or healthcare. But in the grand scheme of things in healthcare IT (HIT),
by John Moore | December 16, 2016
As has become a tradition here at Chilmark Research, it is time once again to look back at our predictions for 2016 and make an honest assessment of just how accurate we were. We do like to go beyond the blatantly obvious predictions that seem so prevalent - we push
by John Moore | September 29, 2016
For my young daughter, 10 yrs is nearly a lifetime - but for myself, nary the blink of an eye. So it felt this week while attending the 10th annual Health 2.0 conference, one part so much time has past, another just a flash. Over those ten years I have
by John Moore | December 21, 2015
Never a dull moment in healthcare. 2015 saw plenty of changes and some inklings as to what may be in store for us in 2016. While there was plenty of noise around ICD-10, it was a non-event in 2015. Likewise, while there was plenty of noise around interoperability in 2015,
by John Moore | December 15, 2015
What good are predictions and the prognosticators who make them if they never go back and assess those predictions later? A big fat goose egg, or worse, if you set some aspects of your strategic plan in alignment with those predictions. The annual predictions that we and other industry followers
